
-
Iran delegation in Oman for high-stakes nuclear talks with US
-
Australia beat Colombia to end BJK Cup bid on winning note
-
German refinery's plight prompts calls for return of Russian oil
-
Trump carves up world and international order with it
-
Paris theatre soul-searching after allegations of sexual abuse
-
US, Iran to hold high-stakes nuclear talks
-
Frustrated families await news days after 222 killed in Dominican club disaster
-
Jokic triple double as Denver fight back for big win
-
Trump envoy suggests allied zones of control in Ukraine
-
Iraqi markets a haven for pedlars escaping Iran's economic woes
-
Chinese manufacturers in fighting spirits despite scrapped US orders
-
Argentina receives $42 bn from international financial institutions
-
Menendez brothers' resentencing can go ahead: LA judge rules
-
'Hard on the body': Canadian troops train for Arctic defense
-
Trump, 78, says feels in 'very good shape' after annual checkup
-
McKellar 'very, very proud' after 'Tahs tame rampant Chiefs
-
Man executed by firing squad in South Carolina
-
Defending champ Scheffler three back after tough day at Augusta
-
Ballester apologizes to Augusta National for relief in Rae's Creek
-
Scorching Coachella kicks off as Lady Gaga set to helm main stage
-
McIlroy, DeChambeau charge but Rose clings to Masters lead
-
Langer misses cut to bring 41st and final Masters appearance to a close
-
Ecuador presidential hopefuls make last pitch to voters
-
Rose knocking on the door of a major again at the Masters
-
DeChambeau finding right balance at Augusta National
-
Spurs leaker not a player says Postecoglou
-
All Black Barrett helps Leinster into Champions Cup semis
-
Round-two rebound: Resilient McIlroy right back in the Masters hunt
-
Asset flight challenges US safe haven status
-
Menendez brothers appear in LA court for resentencing hearing
-
McIlroy, DeChambeau charge as Rose clings to Masters lead
-
UN seeks $275 million in aid for Myanmar quake survivors
-
Frustrated families await news days after 221 killed in Dominican club disaster
-
Trump wants to halt climate research by key agency: reports
-
Fed official says 'absolutely' ready to intervene in financial markets
-
Slumping Homa happy to be headed into weekend at the Masters
-
Morbidelli fastest ahead of cagey MotoGP title rivals in Qatar practise
-
Musetti stuns Monte Carlo Masters champion Tsitsipas to reach semis
-
Abuse scandal returns to haunt the flying 'butterflies' of Italian gymnastics
-
Trump defends policy after China hits US with 125% tariffs
-
Frustrated families await news days after Dominican club disaster
-
McLarens dominate Bahrain practice, Verstappen rues 'too slow' Red Bull
-
Eight birdies rescue Masters rookie McCarty after horror start
-
RFK Jr's autism 'epidemic' study raises anti-vaxx fears
-
Trump -- oldest elected US president -- undergoes physical
-
Rose clings to Masters lead as McIlroy, DeChambeau charge
-
Brazil's Bolsonaro hospitalized with abdominal pain, 'stable'
-
Canada, US to start trade talks in May: Carney
-
Six arrested for murder of notorious Inter Milan ultra
-
Pig kidney removed from US transplant patient, but she set record

US cracks down on 'tranq' drug linked to fatal overdoses
The United States announced Tuesday a crackdown on unlawful imports of xylazine, an animal tranquilizer known as the "zombie drug" and which is increasingly linked to overdose deaths.
Xylazine, which also goes by the street name "tranq," has recently been found in illicitly manufactured fentanyl, heroin, cocaine and other drugs, presenting a "growing public health concern," the Food and Drug Administration (FDA) said.
"This action aims to prevent the drug from entering the US market for illicit purposes, while maintaining availability for its legitimate uses in animals," it said in a statement.
According to the National Institute on Drug Abuse, the percentage of all drug overdose deaths involving xylazine increased from two percent to 26 percent in the northeast state of Pennsylvania from 2015 to 2020.
Xylazine is typically used by veterinarians to sedate large animals such as horses and deer but the drug is not approved for use in humans.
It can slow breathing, blood pressure and heart rate to critically low levels and cause skin ulcers and abscesses that can lead to amputation.
The FDA said imports of xylazine would be subject to heightened scrutiny and seized if they appear to be unlawful.
"The FDA remains concerned about the increasing prevalence of xylazine mixed with illicit drugs, and this action is one part of broader efforts the agency is undertaking to address this issue," FDA commissioner Robert Califf said.
Y.Nakamura--AMWN